Clinical trial
SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+…
NCT00440271 · Boehringer Ingelheim, Industry · Terminated
Key facts
| NCT number | NCT00440271 |
|---|---|
| Title | SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC |
| Official title | SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavi/r IN Race/Gender HIV+ Patients Randomized to Therapeutic Drug Monitoring or Standard of Care |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | tipranavir, ritonavir, Optimized Background Regimen (OBR) |
| Enrollment | 33 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| First posted | Feb 27, 2007 |
| Last update posted | Jun 27, 2014 |
| Countries | Argentina, Brazil, Canada, Germany, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: